Home › Research › Topics › adni
adni
4 studies tagged adni, dated 2011-02-11 to 2024-08-06. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
4 studies carry this tag.
Date range
2011 to 2024
Top journals
- Acta neuropathologica 1
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Neurology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
48/100
The Alzheimer's Disease Neuroimaging Initiative (ADNI) PET Core has evolved over time, beginning with positron emission tomography (PET) imaging of a subsample of participants with [ 18 F]fluorodeoxyglucose (FDG)-PET, adding tracers for measurement of β-amyloid, followed by tau tracers.
-
Plasma and CSF AD biomarkers may perform similarly across diverse populations but future studies in large, diverse cohorts are needed.
-
64/100
Aβ-positive individuals can remain tau-negative for at least 5 years.
-
To account for the combined effects on overall precision of CSF samples (fixed effect), different laboratories and analytical runs (random effects), these data were analyzed by mixed-effects modeling with the following results: within center %CV 95% CI values (mean) of 4.0-6.0% (5.3%) for CSF Aβ(1-42); 6.4-6.8% (6.7%) for t-tau and 5.5-18.0% (10.8%) for p-tau(181) and inter-center %CV 95% CI range of 15.9-19.8% (17.9%) for Aβ(1-42), 9.6-15.2% (13.1%) for t-tau and 11.3-18.2% (14.6%) for p-tau(181).